John L Gore1. 1. Department of Urology, Seattle Cancer Care Alliance, University of Washington, 1959 NE Pacific St, Box 356510, Seattle, WA, 98195, USA. jlgore@uw.edu.
Abstract
PURPOSE OF REVIEW: To summarize current knowledge on patient-prioritized outcomes for their bladder cancer care. RECENT FINDINGS: Patient-centered outcomes research seeks to help patients identify the right treatment for the right patient at the right time in their care. As such, patient-centered outcomes research relies on studying a treatment's impact on patient-centered outcomes. Some outcomes, like survival, are commonly prioritized by patients and by clinical experts. Patients often place greater emphasis than experts on quality of life outcomes. Thus, many patient-centered outcomes are also patient-reported outcomes. Unique domains that are often prioritized by patients, but overlooked by experts, include the costs and financial impact of care, anxiety, and depression related to a health condition, and the impact of a condition or its treatment on a caregiver or loved one. Patient-centered outcomes are realizing greater recognition for their innate importance and potential to augment the impact of research studies. Although patient-centered outcomes are often patient-reported outcomes, this is not universal. Unique to bladder cancer, the availability of a research-oriented Patient Survey Network intended to identify research questions that are important to patients may be an opportunity to broadly solicit input on patient-centered outcomes for bladder cancer research questions.
PURPOSE OF REVIEW: To summarize current knowledge on patient-prioritized outcomes for their bladder cancer care. RECENT FINDINGS:Patient-centered outcomes research seeks to help patients identify the right treatment for the right patient at the right time in their care. As such, patient-centered outcomes research relies on studying a treatment's impact on patient-centered outcomes. Some outcomes, like survival, are commonly prioritized by patients and by clinical experts. Patients often place greater emphasis than experts on quality of life outcomes. Thus, many patient-centered outcomes are also patient-reported outcomes. Unique domains that are often prioritized by patients, but overlooked by experts, include the costs and financial impact of care, anxiety, and depression related to a health condition, and the impact of a condition or its treatment on a caregiver or loved one. Patient-centered outcomes are realizing greater recognition for their innate importance and potential to augment the impact of research studies. Although patient-centered outcomes are often patient-reported outcomes, this is not universal. Unique to bladder cancer, the availability of a research-oriented Patient Survey Network intended to identify research questions that are important to patients may be an opportunity to broadly solicit input on patient-centered outcomes for bladder cancer research questions.
Entities:
Keywords:
Bladder cancer; Health outcomes; Patient-centered outcomes research; Quality of life
Authors: Kevin Koo; Lisa Zubkoff; Brenda E Sirovich; Philip P Goodney; Douglas J Robertson; John D Seigne; Florian R Schroeck Journal: Urology Date: 2017-07-21 Impact factor: 2.649
Authors: Alicia K Morgans; Annelotte C M van Bommel; Caleb Stowell; Janet L Abrahm; Ethan Basch; Justin E Bekelman; Donna L Berry; Alberto Bossi; Ian D Davis; Theo M de Reijke; Louis J Denis; Sue M Evans; Neil E Fleshner; Daniel J George; Jim Kiefert; Daniel W Lin; Andrew G Matthew; Ray McDermott; Heather Payne; Ian A G Roos; Deborah Schrag; Thomas Steuber; Bertrand Tombal; Jean-Paul van Basten; Jacobus J M van der Hoeven; David F Penson Journal: Eur Urol Date: 2015-06-28 Impact factor: 20.096
Authors: Halina Sklenarova; Arne Krümpelmann; Markus W Haun; Hans-Christoph Friederich; Johannes Huber; Michael Thomas; Eva C Winkler; Wolfgang Herzog; Mechthild Hartmann Journal: Cancer Date: 2015-02-11 Impact factor: 6.860
Authors: N K Aaronson; S Ahmedzai; B Bergman; M Bullinger; A Cull; N J Duez; A Filiberti; H Flechtner; S B Fleishman; J C de Haes Journal: J Natl Cancer Inst Date: 1993-03-03 Impact factor: 13.506